Biogen Inc. (BIIB) 재무상태표
NASDAQ · Healthcare · Drug Manufacturers - General · 직원 7,500명 · CEO Christopher A. Viehbacher
- 주가
- $253.62 +1.59%
- 시가총액
- $375억
- 기업가치
- $440억
- 최근 실적
- Q3 '26 2026-10-28 제출
- 다음 실적
- 2027-02-05 EPS 추정 $2.85
Biogen Inc. (BIIB)의 Q3 '26말 현금 및 단기투자는 $13억, 리스 포함 차입금은 $78억입니다. 자산총계 $321억, 부채총계 $131억, 주주지분 $189억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $10.5억 | $10.7억 | $19.1억 | $17억 | $23.8억 | $26억 | $27.6억 | $38.6억 | $30.1억 | $33.8억 | $12.9억 | $13억 | |
| 단기투자 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9760만 | $8.07억 | $9억 | $0 | $0 | |
| 매출채권 | $21억 | $20억 | $20.8억 | $19.9억 | $18.7억 | $20억 | $20.8억 | $18.5억 | $18.7억 | $17.9억 | $18.9억 | $18.8억 | |
| 재고자산 | $25.3억 | $25.2억 | $25.1억 | $24.7억 | $24.6억 | $22.7억 | $22.7억 | $22.1억 | $21.7억 | $19.5억 | $23.8억 | $22.2억 | |
| 기타 유동자산 | $11.8억 | $11.7억 | $6.15억 | $6.74억 | $7.53억 | $7.57억 | $8.51억 | $9.17억 | $11.2억 | $11.7억 | $17.5억 | $21.7억 | |
| 유동자산 | $68.6억 | $67.6억 | $71.1억 | $68.3억 | $74.6억 | $76.3억 | $79.7억 | $89.4억 | $89.7억 | $91.9억 | $73.1억 | $75.8억 | |
| 유형자산(순액) | $37.3억 | $37억 | $36.4억 | $35.9억 | $35.4억 | $34.8억 | $34.3억 | $34.1억 | $33.2억 | $32.7억 | $32.4억 | $31.4억 | |
| 장기투자 | $4.61억 | $3.82억 | $3.54억 | $3.53억 | $2.27억 | $1.86억 | $2.24억 | $1.67억 | $7.51억 | $4.66억 | $8.32억 | $6.6억 | |
| 영업권 | $62.2억 | $62.3억 | $62.3억 | $64.9억 | $64.8억 | $64.8억 | $64.9억 | $64.9억 | $64.9억 | $64.9억 | $69.9억 | $69.9억 | |
| 무형자산 | $83.6억 | $82.8억 | $82.3억 | $98.1억 | $96.9억 | $95.8억 | $94.7억 | $93.3억 | $91.8억 | $90.5억 | $135억 | $134억 | |
| 이연법인세자산 | $9.29억 | $8.98억 | $9.15억 | $9.69억 | $3.24억 | $3.08억 | $3.31억 | $3.12억 | $2.93억 | $2.38억 | $2.02억 | $2.94억 | |
| 기타 비유동자산 | $2.84억 | $3.16억 | $3.27억 | $2.78억 | $3.34억 | $3.73억 | $4.14억 | $5.63억 | $4.32억 | $7.78억 | $0 | $0 | |
| 비유동자산 | $200억 | $198억 | $197억 | $215억 | $206억 | $204억 | $204억 | $203억 | $205억 | $203억 | $248억 | $245억 | |
| 자산총계 | $268억 | $266억 | $268억 | $283억 | $280억 | $280억 | $283억 | $292억 | $294억 | $295억 | $321억 | $321억 | |
| 부채 | |||||||||||||
| 매입채무 | $4.03억 | $3.87억 | $3.55억 | $4.23억 | $4.24억 | $3.92억 | $4.08억 | $4.13억 | $4.32억 | $3.59억 | $4.04억 | $4.3억 | |
| 미지급비용 | $22.9억 | $14.8억 | $15.5억 | $18.3억 | $24.3억 | $23.4억 | $22.8억 | $23.7억 | $0 | $23.5억 | $22.4억 | $20.5억 | |
| 단기차입금 | $1.5억 | $2.5억 | $0 | $17.5억 | $17.5억 | $17.5억 | $0 | $0 | $8040만 | $0 | $8억 | $4억 | |
| 미지급세금 | $2.57억 | $2.31억 | $2.82억 | $4.99억 | $5.48억 | $6.26억 | $1.15억 | $1.03억 | $1.15억 | $9360만 | $8690만 | $0 | |
| 기타 유동부채 | $3.35억 | $8.79억 | $9.18억 | $9.26억 | $3.76억 | $1.92억 | $3.85억 | $4억 | $27.2억 | $1.93억 | $3.91억 | $10.1억 | |
| 유동부채 | $34.3억 | $32.2억 | $31.1억 | $54.3억 | $55.3억 | $53억 | $31.8억 | $32.9억 | $33.5억 | $30억 | $39.2억 | $39억 | |
| 장기차입금 | $67.9억 | $62.9억 | $62.9억 | $45.5억 | $45.5억 | $45.5억 | $62.8억 | $62.9억 | $65.8억 | $62.9억 | $72.9억 | $72.9억 | |
| 리스부채(비유동) | $4억 | $4.07억 | $3.68억 | $3.57억 | $3.35억 | $3.23억 | $3.11억 | $3.05억 | $2.9억 | $2.73억 | $2.65억 | $1.09억 | |
| 이연법인세부채 | $6.42억 | $6.58억 | $5.91억 | $8.82억 | $1.91억 | $1.33억 | $1.18억 | $3.58억 | $5.08억 | $4.84억 | $9.46억 | $11.6억 | |
| 기타 비유동부채 | $7.81억 | $7.77억 | $5.57억 | $7.44억 | $7.32억 | $7.52억 | $8억 | $7.62억 | $4.58억 | $7.87억 | $8.21억 | $6.68억 | |
| 비유동부채 | $86.1억 | $81.3억 | $78.1억 | $65.3억 | $58억 | $57.6억 | $75.1억 | $77.1억 | $78.3억 | $78.3억 | $93.2억 | $92.3억 | |
| 부채총계 | $120억 | $114억 | $109억 | $120억 | $113억 | $111억 | $107억 | $110억 | $112억 | $108억 | $132억 | $131억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | |
| 이익잉여금 | $176억 | $180억 | $186억 | $190억 | $193억 | $195억 | $201억 | $206억 | $206억 | $209억 | $210억 | $209억 | |
| 기타포괄손익누계액 | -$1.54억 | -$1.61억 | -$1.46억 | -$1.46억 | -$1.36억 | -$1.75억 | -$2.38억 | -$2.15억 | -$1.82억 | -$1.4억 | -$1.28억 | -$1.2억 | |
| 주주지분 | $148억 | $152억 | $159억 | $164억 | $167억 | $170억 | $176억 | $182억 | $183억 | $187억 | $188억 | $189억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $73.4억 | $69.5억 | $66.6억 | $66.5억 | $66.3억 | $66.2억 | $65.9억 | $65.9억 | $69.5억 | $65.6억 | $83.6억 | $78억 | |
| 순차입금(차입금 - 현금) | $62.9억 | $58.7억 | $47.5억 | $49.5억 | $42.6억 | $40.2억 | $38.4억 | $27.3억 | $39.4억 | $31.8억 | $70.7억 | $65억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $23.3억 | $15.7억 | $12.2억 | $29.1억 | $13.3억 | $22.6억 | $34.2억 | $10.5억 | $23.8억 | $30.1억 | |
| 단기투자 | $25.7억 | $21.2억 | $23.1억 | $15.6억 | $12.8억 | $15.4억 | $14.7억 | $0 | $0 | $8.07억 | |
| 매출채권 | $17.4억 | $23.2억 | $24.9억 | $24.7억 | $23.3억 | $19.6억 | $21.4억 | $21억 | $18.7억 | $18.7억 | |
| 재고자산 | $10억 | $9.03억 | $9.3억 | $8.04억 | $10.7억 | $13.5억 | $13.4억 | $25.3억 | $24.6억 | $21.7억 | |
| 기타 유동자산 | $2.76억 | $3.04억 | $6.88억 | $6.31억 | $8.81억 | $7.41억 | $14.2억 | $11.8억 | $7.53억 | $11.2억 | |
| 유동자산 | $87.3억 | $78.7억 | $76.4억 | $83.8억 | $68.9억 | $78.6억 | $97.9억 | $68.6억 | $74.6억 | $89.7억 | |
| 유형자산(순액) | $25억 | $31.8억 | $36억 | $36.7억 | $38.4억 | $37.9억 | $37억 | $37.3억 | $35.4억 | $33.2억 | |
| 장기투자 | $28.3억 | $30.6억 | $13.8억 | $14.1억 | $7.72억 | $8.92억 | $7.06억 | $4.61억 | $2.27억 | $7.51억 | |
| 영업권 | $36.7억 | $46.3억 | $57.1억 | $57.6억 | $57.6억 | $57.6억 | $57.5억 | $62.2억 | $64.8억 | $64.9억 | |
| 무형자산 | $38.1억 | $38.8억 | $31.2억 | $35.3억 | $30.8억 | $22.2억 | $18.5억 | $83.6억 | $96.9억 | $91.8억 | |
| 이연법인세자산 | $0 | $5.96억 | $21.5억 | $32.3억 | $13.7억 | $14.2억 | $12.3억 | $9.29억 | $3.24억 | $2.93억 | |
| 기타 비유동자산 | $13.4억 | $4.32억 | $16.9억 | $12.5억 | $29억 | $19.4억 | $15.3억 | $2.84억 | $3.34억 | $4.32억 | |
| 비유동자산 | $141억 | $158억 | $176억 | $189억 | $177억 | $160억 | $148억 | $200억 | $206억 | $205억 | |
| 자산총계 | $229억 | $237억 | $253억 | $272억 | $246억 | $239억 | $246억 | $268억 | $280억 | $294억 | |
| 부채 | |||||||||||
| 매입채무 | $2.8억 | $3.96억 | $3.71억 | $5.31억 | $4.55억 | $5.89억 | $4.92억 | $4.03억 | $4.24억 | $4.32억 | |
| 미지급비용 | $26.2억 | $26억 | $25.4억 | $24.5억 | $26.3억 | $21.9억 | $13.8억 | $22.9억 | $24.3억 | $0 | |
| 단기차입금 | $470만 | $320만 | $0 | $15억 | $0 | $9.99억 | $0 | $1.5억 | $17.5억 | $8040만 | |
| 미지급세금 | $2.32억 | $6820만 | $6350만 | $7140만 | $1.42억 | $1.75억 | $2.6억 | $2.57억 | $5.48억 | $1.15억 | |
| 기타 유동부채 | $2.83억 | $2.98억 | $3.21억 | $3.16억 | $5.15억 | $3.45억 | $11.4억 | $3.35억 | $3.76억 | $27.2억 | |
| 유동부채 | $34.2억 | $33.7억 | $33억 | $48.6억 | $37.4억 | $43억 | $32.7억 | $34.3억 | $55.3억 | $33.5억 | |
| 장기차입금 | $65.1억 | $59.4억 | $59.4억 | $44.6억 | $74.3억 | $62.7억 | $62.8억 | $67.9억 | $45.5억 | $65.8억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $4.13억 | $4.02억 | $3.3억 | $3.33억 | $4억 | $3.35억 | $2.9억 | |
| 이연법인세부채 | $9310만 | $1.23억 | $16.4억 | $28.1억 | $10.3억 | $6.95억 | $3.35억 | $6.42억 | $1.91억 | $5.08억 | |
| 기타 비유동부채 | $7.23억 | $16.3억 | $13.9억 | $13.5억 | $13.3억 | $13.2억 | $9.44억 | $7.81억 | $7.32억 | $4.58억 | |
| 비유동부채 | $73.3억 | $76.9억 | $89.6억 | $90.3억 | $102억 | $86.2억 | $78.9억 | $86.1억 | $58억 | $78.3억 | |
| 부채총계 | $107억 | $111억 | $123억 | $139억 | $139억 | $129억 | $112억 | $120억 | $113억 | $112억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | $10만 | |
| 이익잉여금 | $151억 | $158억 | $163억 | $165억 | $140억 | $139억 | $165억 | $176억 | $193억 | $206억 | |
| 기타포괄손익누계액 | -$3.2억 | -$3.18억 | -$2.4억 | -$1.35억 | -$2.99억 | -$1.07억 | -$1.65억 | -$1.54억 | -$1.36억 | -$1.82억 | |
| 주주지분 | $121억 | $126억 | $130억 | $133억 | $107억 | $109억 | $134억 | $148억 | $167억 | $183억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $65.2억 | $59.4억 | $59.4억 | $63.7억 | $78.3억 | $76억 | $66.1억 | $73.4억 | $66.3억 | $69.5억 | |
| 순차입금(차입금 - 현금) | $41.9억 | $43.6억 | $47.1억 | $34.5억 | $65억 | $53.4억 | $31.9억 | $62.9억 | $42.6억 | $39.4억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
데이터 기준일 2026-11-02